FRANKLIN LAKES, N.J. , Aug.
12, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX ), a leading global medical technology company, announced today that Michael Feld has been named executive vice president and president of the Life Sciences segment for BD, effective Aug. 20, 2024 , and will serve as a member of the Executive Leadership Team. He succeeds Dave Hickey , who retired from BD last month after 10 years with the company.
Feld joins BD from Veralto, a spin-off of Danaher, where he was most recently president of Hach, a global leader in water quality products. Prior to that, Feld held several senior roles at Danaher, including senior vice president and general manager of Cepheid Europe, and served as president of several other Danaher businesses including Mammotome, XOS and Dover Motion, all focused on strategic planning, superior quality, associate development and cultural progression. "Mike's expertise in applying commercial and operational excellence principles to deliver impactful results, coupled with his experience in diagnostic solutions, position him well to lead our Life Sciences segment," said Tom Polen , chairman, CEO and president of BD.
"As we build momentum behind our BD Excellence operating system, Mike's continuous improvement mindset will be an asset to BD as our Life Sciences team continues to drive efficiencies and meaningfully expand value for our customers, their patients and the global healthcare ecosystem." As president of the BD L.